Literature DB >> 3409045

Early appearance of type II astrocytes in developing human fetal brain.

G A Elder1, E O Major.   

Abstract

To compare rat and human glial development, we examined the cellular composition of human fetal brain in short-term cultures and fresh cell suspensions from fetal ages ranging from 7 to 16 weeks, utilizing the cell type-specific markers which define glial subsets in rats. Here we report that unlike the early rat central nervous system (CNS), 7-10 week human fetal brain contains mostly astrocytes that can be characterized as type II rather than type I. Type I astrocytes become more prevalent in 16-week gestational age human brain. Although cells morphologically and immunocytochemically similar to the rat 02-A cell are found in human fetal brain and spinal cord, these cells were not induced to express galactocerebroside in serum-free media and did not have vimentin-containing intermediate filaments as do rat 02-A cells. These results suggest that functional differences may exist between rat type I and type II astrocytes and phenotypically similar cells found in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409045     DOI: 10.1016/0165-3806(88)90211-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Organotypic cultures of free-floating slices of human embryo medulla oblongata.

Authors:  V M Vostrikov; N S Kolomeets; O P Aleksandrova; I V Viktorov; N A Uranova; G T Sukhikh
Journal:  Neurosci Behav Physiol       Date:  2005-01

2.  Glial cell differentiation in neuron-free and neuron-rich regions. I. Selective appearance of S-100 protein in radial glial cells of the hippocampal fimbria in human fetuses.

Authors:  M Stagaard Janas; R S Nowakowski; O B Terkelsen; K Møllgård
Journal:  Anat Embryol (Berl)       Date:  1991

3.  The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.

Authors:  S P Lim; A Garzino-Demo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.

Authors:  M P Heyes; C Y Chen; E O Major; K Saito
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

5.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.

Authors:  K Conant; M Ma; A Nath; E O Major
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

Authors:  M P Heyes; C L Achim; C A Wiley; E O Major; K Saito; S P Markey
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

7.  Human fetal Schwann cells support JC virus multiplication.

Authors:  J G Assouline; E O Major
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  Glial cell differentiation in neuron-free and neuron-rich regions. II. Early appearance of S-100 protein positive astrocytes in human fetal hippocampus.

Authors:  M Stagaard Janas; R S Nowakowski; K Møllgård
Journal:  Anat Embryol (Berl)       Date:  1991

Review 9.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

10.  Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes.

Authors:  Jiwen Li; Lin Pan; William G Pembroke; Jessica E Rexach; Marlesa I Godoy; Michael C Condro; Alvaro G Alvarado; Mineli Harteni; Yen-Wei Chen; Linsey Stiles; Angela Y Chen; Ina B Wanner; Xia Yang; Steven A Goldman; Daniel H Geschwind; Harley I Kornblum; Ye Zhang
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.